A New Way In: How Outside-the-box Science Sparked a Revolution in Targeting KRAS

At the recent AACR Conference on Pancreatic Cancer, Kevan M. Shokat, PhD, FAACR, received the 2026 Stephenson Global Prize for his pioneering discoveries that opened the door to the development of RAS-targeted therapies. Read the post to learn more on the scientific journey that led to new drugs for cancer treatment, including the first major systemic therapy advance in metastatic pancreatic cancer in more than a decade.

The post A New Way In: How Outside-the-box Science Sparked a Revolution in Targeting KRAS appeared first on American Association for Cancer Research (AACR).

Source: Oncology

Read More